SCHEMBL23330848

SCHEMBL23330848

COC(=O)CCC(=O)c1cc(-c2ccccc2)cs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.49
MMP12 P39900 4/20 0.47
DGAT1 O75907 1/20 0.43
LMNA P02545 4/20 0.42
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALAD P13716 2/20 0.41
CTNNB1 P35222 1/20 0.41
WNT3A P56704 1/20 0.41
RAB9A P51151 2/20 0.41
LTB4R Q15722 1/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
STING1 Q86WV6 1/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23330721 0.88 HDAC6 (0.51) HDAC6MMP12DGAT1ALDH1A1KDM4E
SCHEMBL23330930 0.84 ADORA1 (0.40) HDAC6LMNAALDH1A1KDM4ERAB9A
SCHEMBL23300707 0.83 HDAC6 (0.55) HDAC6MMP12LMNAALDH1A1ALAD
SCHEMBL242998 0.82 SMN1; SMN2 (0.56) HDAC6MMP12DGAT1LMNAALAD
SCHEMBL29831249 0.81 CYP2C19 (0.47) HDAC6LMNAALDH1A1KDM4EMEN1
SCHEMBL23330455 0.81 CYP2C19 (0.47) HDAC6LMNAALDH1A1KDM4EMEN1
SCHEMBL23300916 0.81 ERN1 (0.43) LMNAALDH1A1KDM4ECTNNB1WNT3A
SCHEMBL27688659 0.79 HDAC6 (0.57) HDAC6MMP12DGAT1ALDH1A1KDM4E
SCHEMBL24932418 0.79 HDAC6 (0.57) HDAC6MMP12DGAT1LMNAALAD
SCHEMBL2326735 0.79 HDAC6 (0.57) HDAC6MMP12DGAT1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112724127-B Five-membered heterocyclic oxocarboxylic acid compound and medical application thereof 中国科学院上海药物研究所 2023-02-17 CN disclosed
US-20230032101-A1 FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2023-02-02 US disclosed
EP-4053124-A1 FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2022-09-07 EP disclosed
CN-114829357-A Five-membered heterocyclic oxocarboxylic acid compound and medical application thereof 中国科学院上海药物研究所 2022-07-29 CN disclosed
WO-2021083060-A1 FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF 中国科学院上海药物研究所 2021-05-06 WO disclosed
CN-112724127-A Five-membered heterocyclic oxocarboxylic acid compound and medical application thereof 中国科学院上海药物研究所 2021-04-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230032101-A1 FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF STING1, CGAS, IRF3 HDAC6 1430/4885MMP12 1419/4885DGAT1 2398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.